Antipsychotic drugs alter neuronal development including ALM neuroblast migration and PLM axonal outgrowth in Caenorhabditis elegans

International Journal of Developmental Neuroscience

Volumn 26, Issue 3-4, 2008, Pages 371-380

  Donohoe, Dallas R ^a   Weeks, Kathrine ^a   Aamodt, Eric J ^a   Dwyer, Donard S ^a,b  

^a LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^b Louisiana State University School of Medicine Shreveport   (United States)

Author keywords

Antipsychotic drugs; Axon outgrowth; Neuronal migration

Indexed keywords

ARIPIPRAZOLE; CHLORPROMAZINE; CLOZAPINE; CLOZAPINE N OXIDE; FLUPHENAZINE; FUNGAL PROTEIN; GREEN FLUORESCENT PROTEIN; HALOPERIDOL; NEUROLEPTIC AGENT; OLANZAPINE; QUETIAPINE; RISPERIDONE; SEROTONIN; TRIFLUOPERAZINE;

ARTICLE; CAENORHABDITIS ELEGANS; CELL MIGRATION; CONTROLLED STUDY; NERVE CELL DIFFERENTIATION; NERVE FIBER GROWTH; NEUROBLAST; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SENSORY NERVE CELL;

ANIMALS; ANTIPSYCHOTIC AGENTS; CAENORHABDITIS ELEGANS; CELL DIFFERENTIATION; CELL MOVEMENT; DOPAMINE AGONISTS; DOSE-RESPONSE RELATIONSHIP, DRUG; GROWTH CONES; NERVOUS SYSTEM; NERVOUS SYSTEM MALFORMATIONS; NEURONS, AFFERENT; RECEPTORS, DOPAMINE; STEM CELLS;

CAENORHABDITIS ELEGANS; RATTUS;

EID: 41649112915     PISSN: 07365748     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijdevneu.2007.08.021     Document Type: Article

References (43)

1. Ansorge M.S., Zhou M., Lira A., Hen R., and Gingrich J.A. Early-life blockade of the 5-HT transporter alters emotional behavior in adult mice. Science 306 (2004) 879-881
2. Azmitia E.C. Modern views on an ancient chemical: serotonin effects on cell proliferation, maturation, and apoptosis. Brain Res. Bull. 56 (2001) 413-424
3. Baldessarini R.J., Centorrino F., Flood J.G., Volpicelli S.A., Huston-Lyons D., and Cohen B.M. Tissue concentrations of clozapine and its metabolites in the rat. Neuropsychopharmacology 9 (1993) 117-124
4. Branda C.S., and Stern M.J. Cell migration and axon growth cone guidance in Caenorhabditis elegans. Curr. Opin. Genet. Dev. 9 (1999) 479-484
5. Brenner S. The genetics of Caenorhabditis elegans. Genetics 77 (1974) 71-94
6. Brigman J.L., Padukiewicz K.E., Sutherland M.L., and Rothblat L.A. Executive functions in the heterozygous reeler mouse model of schizophrenia. Behav. Neurosci. 120 (2006) 984-988
7. Carboni G., Tueting P., Tremolizzo L., Sugaya I., Davis J., and Guidotti A. Enhanced dizocilpine efficacy in heterozygous reeler mice relates to GABA turnover downregulation. Neuropharmacology 46 (2004) 1070-1081
8. Chalfie M., Sulston J.E., Whire J.G., Southgate E., Thomson J.N., and Brenner S. The neural circuit for touch sensitivity in Caenorhabditis elegans. J. Neurosci. 5 (1985) 956-964
9. Dahl S.G. Plasma level monitoring of antipsychotic drugs. Clinical utility. Clin. Pharmacokinet. 11 (1986) 336-361
10. Di Michele V., Ramenghi L.A., and Sabatino G. Clozapine and lorazepam administration in pregnancy. Eur. Psychiatry 11 (1996) 214
11. Donohoe D.R., Aamodt E.J., Osborn E., and Dwyer D.S. Antipsychotic drugs disrupt normal development in Caenorhabditis elegans via additional mechanisms besides dopamine and serotonin receptors. Pharmacol. Res. 54 (2006) 361-372
12. Findling R.L., Schulz S.C., Reed M.D., and Blumer J.L. The antipsychotics. A pediatric perspective. Pediatr. Clin. North Am. 45 (1998) 1205-1232
13. Hao J.C., Yu T.W., Fujisawa K., Culotti J.G., Gengyo-Ando K., Mitani S., Moulder G., Barstead R., Tessier-Lavigne M., and Bargmann C.I. C. elegans slit acts in midline, dorsal-ventral, and anterior-posterior guidance via the SAX-3/Robo receptor. Neuron 32 (2001) 25-38
14. Hatten M.E. New directions in neuronal migration. Science 297 (2002) 1660-1663
15. Heiser P., Schuler-Springorum M., Schulte E., Hausmann C., Remschmidt H., Krieg J.C., and Vedder H. Pharmacokinetics of clozapine and its metabolites in hippocampal HT22 cells. Eur. J. Pharmacol. 476 (2003) 167-172
16. Hekimi S., and Kershaw D. Axonal guidance defects in a Caenorhabditis elegans mutant reveal cell-extrinsic determinants of neuronal morphology. J. Neurosci. 13 (1993) 4254-4271
17. Holson R.R., Webb P.J., Grafton T.F., and Hansen D.K. Prenatal neuroleptic exposure and growth stunting in the rat: an in vivo and in vitro examination of sensitive periods and possible mechanisms. Teratology 50 (1994) 125-136
18. Jann M.W., Grimsley S.R., Gray E.C., and Chang W.H. Pharmacokinetics and pharmacodynamics of clozapine. Clin. Pharmacokinet. 24 (1993) 161-176
19. Jassen A.K., Yang H., Miller G.M., Calder E., and Madras B.K. Receptor regulation of gene expression of axon guidance molecules: implications for adaptation. Mol. Pharmacol. 70 (2006) 71-77
20. Kindt K.S., Tam T., Whiteman S., and Schafer W.R. Serotonin promotes G(o)-dependent neuronal migration in Caenorhabditis elegans. Curr. Biol. 12 (2002) 1738-1747
21. Klee C.B. Concerted regulation of protein phosphorylation and dephosphorylation by calmodulin. Neurochem. Res. 16 (1991) 1059-1065
22. Kornhuber J., Schultz A., Wiltfang J., Meineke I., Gleiter C.H., Zoechling R., Boissl K., Leblhuber F., and Riederer P. Persistence of haloperidol in human brain tissue. Am. J. Psychiatry 156 (1999) 885-890
23. Lanczik M., Knoche M., and Fritze J. Psychopharmacotherapy during pregnancy and lactation. I. Pregnancy. Nervenarzt 69 (1998) 1-9
24. Luo X., Persico A.M., and Lauder J.M. Serotonergic regulation of somatosensory cortical development: lessons from genetic mouse models. Dev. Neurosci. 25 (2003) 173-183
25. Meltzer H.Y., Matsubara S., and Lee J.C. The ratios of serotonin 2 and dopamine 2 affinities differentiate atypical and typical antipsychotic drugs. Psychopharmacol. Bull. 25 (1989) 390-392
26. Meltzer H.Y., Li Z., Kaneda Y., and Ichikawa J. Serotonin receptors: their key role in drugs to treat schizophrenia. Prog. Neuropsychopharmacol. Biol. Psychiatry 27 (2003) 1159-1172
27. Merz D.C., and Culotti J.G. Genetic analysis of growth cone migration in Caenorhabditis elegans. J. Neurobiol. 44 (2000) 281-288
28. Meyer M.C., Baldessarini R.J., Goff D.C., and Centorrino F. Clinically significant interactions of psychotropic agents with antipsychotic drugs. Drug Safety 15 (1996) 333-346
29. Qin H., and Powell-Coffman J.A. The Caenorhabditis elegans aryl hydrocarbon receptor, AHR-1, regulates neuronal development. Dev. Biol. 270 (2004) 44-75
30. Sanyal S., Wintle R.F., Kindt K.S., Nuttley W.M., Arvan R., Fitzmaurice P., Bigras E., Merz D.C., Herbert T.E., van der Kooy D., Schafer W.R., Culotti J.G., and Van Tol H.H. Dopamine modulates the plasticity of mechanosensory responses in Caenorhabditis elegans. EMBO J. 23 (2004) 473-482
31. Spencer G.E., Klumperman J., and Syed N.I. Neurotransmitters and neurodevelopment. Role of dopamine in neurite outgrowth, target selection, and specific synapse formation. Perspect. Dev. Neurobiol. 5 (1998) 451-467
32. Sze J.Y., Victor M., Loer C., Shi Y., and Ruvkun G. Food and metabolic signaling defects in a Caenorhabditis elegans serotonin-synthesis mutant. Nature 403 (2000) 560-564
33. Talaska G., Ginsburg D., LaDow K., Puga A., Dalton T., and Warshawsky D. Impact of Cyp1a2 or Ahr gene knockout in mice: implications for biomonitoring studies. Toxicol. Lett. 162 (2006) 246-249
34. Toms N., Cooper J., Patchen B., and Aamodt E. High coy arrays containing a sequence upstream of mec-3 alter cell migration and axonal morphology in C. elegans. BMC Dev. Biol. 1 (2001) 2
35. Tsalik E.L., Niacaris T., Wenick A.S., Pau K., Avery L., and Hobert O. LIM homeobox gene-dependent expression of biogenic amine receptors in restricted regions of the C. elegans nervous system. Dev. Biol. 263 (2003) 81-102
36. Wang J.H., Yang J.Z., Wilson F.A., and Ma Y.Y. Differently lasting effects of prenatal and postnatal chronic clozapine/haloperidol on activity and memory in mouse offspring. Pharmacol. Biochem. Behav. 84 (2006) 468-478
37. Watari-Goshima N., Ogura K., Wolf F.W., Goshima Y., and Garriga G. C. elegans VAB-8 and UNC-73 regulate the SAX-3 receptor to direct cell and growth-cone migrations. Nat. Neurosci. 10 (2007) 169-176
38. Weiss B., Prozialeck W., Cimino M., Barnette M.S., and Wallace T.L. Pharmacological regulation of calmodulin. Ann. N.Y. Acad. Sci. 356 (1980) 319-345
39. Wen Z., Guirland C., Ming G.L., and Zheng J.Q. A CaMKII/calcineurin switch controls the direction of Ca(2+)-dependent growth cone guidance. Neuron 43 (2004) 835-846
40. Wolf F.W., Hung M.S., Wightman B., Way J., and Garriga G. vab-8 is a key regulator of posteriorly directed migrations in C. elegans and encodes a novel protein with kinesin motor similarity. Neuron 20 (1998) 655-666
41. Yaeger D., Smith H.G., and Altshuler L.L. Atypical antipsychotics in the treatment of schizophrenia during pregnancy and postpartum. Am. J. Psychiatry 163 (2006) 2064-2070
42. Yoshida K., Smith B., Craggs M., and Kumar R. Neuroleptic drugs in breast-milk: a study of pharmacokinetics and of possible adverse effects in breast-fed infants. Psychol. Med. 28 (1998) 81-91
43. Zito J.M., Safer D.J., dos Reis S., Gardner J.F., Boles M., and Lynch F. Trends in the prescribing of psychotropic medications to preschoolers. JAMA 283 (2000) 1025-1030